MAPT and Alzheimer disease: On the other hand, the progression of β-amyloid and tau pathologies has long been established (Braak and Braak, 1996) and remains the dominant paradigm of AD modeling (Jack et al., 2010; Sperling et al., 2011; Jack and Holtzman, 2013).